Eli Lilly stock surges 11% on obesity pill’s success in first late-stage trial
Eli Lilly’s experimental obesity pill, orforglipron, met its main goals in a closely watched late-stage trial, boosting the company’s standing...
Read moreEli Lilly’s experimental obesity pill, orforglipron, met its main goals in a closely watched late-stage trial, boosting the company’s standing...
Read moreThe European Central Bank on Thursday reduced its key interest rate by 25 basis points, citing easing inflation and mounting...
Read moreHertz Global Holdings (NASDAQ: HTZ) is up nearly 50% in premarket on Thursday after billionaire investor Bill Ackman announced a...
Read moreA wave of caution washed over Asian financial markets on Wednesday, pulling major indices lower as investors contended with lingering...
Read moreShares of British business supplies group Bunzl fell sharply on Wednesday after the company cut its 2025 forecast and paused...
Read moreEuropean stock markets retreated at the open on Wednesday, snapping a two-day winning streak as persistent uncertainty over US trade...
Read moreGoogle is facing a major legal challenge in the United Kingdom, where a class action lawsuit has been filed seeking...
Read moreAs the Trump administration begins reshaping the priorities of US defense spending, investors are seeking clarity on how contractors will...
Read moreJapan’s competition watchdog has ordered Google to stop prioritising its search engine and browser on Android smartphones in a move...
Read moreSingapore has officially entered election season as President Tharman Shanmugaratnam dissolved parliament on Tuesday, acting on the advice of Prime...
Read moreCopyright © 2025 Insightfulword.com. All Rights Reserved.